Metrion’s Sales and Marketing Manager Dr Sophie Rose is attending the One Nucleus collaborative event with Medilink Midlands on “Collaborating to Support Biotech and Med Tech Business Across Our Neighbouring Regions” on March 2 at 10-11AM. The event is focussed on how our two respective groups can collaborate more to support One Nucleus members. As part of the programme, One Nucleus have reserved a short slot for comments from case study members and Sophie will be detailing more about how Metrion Biosciences and One Nucleus have worked together.
Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs. Our state of the art laboratories at Granta Park house high quality facilities for native and engineered cell line and induced pluripotent stem cell culture, a comprehensive suite of automated patch clamp platforms, multiple manual patch clamp rigs, fluorescence-based screening capability and laboratory data management and reporting systems. Our company is focused upon delivering a range of high quality ion channel drug discovery services. We provide highly skilled electrophysiology screening services to support client medicinal chemistry optimisation programmes, CiPA compliant cardiac safety profiling assays, neuroscience assays and translational assays. We combine in depth target class knowledge and high quality screening assays with highly experienced and collaborative drug discovery managers to keep your research focused upon meeting both objectives and timelines. Our team has successfully delivered many projects on behalf of our clients from once off screening projects to fully integrated drug discovery programmes delivering clinical candidates.